12-12-2024, 14:00

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Notified -
Globe Newswire12-12-2024, 14:00
17-04-2024, 13:00

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Globe Newswire17-04-2024, 13:00
8-01-2024, 14:00

Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva
Globe Newswire8-01-2024, 14:00